Tag: biocon
Browse our exclusive articles!
Biocon unit gets US FDA tentative nod for diabetes drug Sitagliptin
Biocon Ltd said on Tuesday its wholly owned unit Biocon Pharma has received tentative approval from the US Food and Drug Administration (US FDA)...
Biocon Q1 Results | Net profit tanks 95% to ₹31 crore, misses estimates
Biotechnology firm Biocon Ltd on Thursday (August 7) reported a steep 95.2% year-on-year (YoY) decline in consolidated net profit at ₹31.4 crore for the...
Biocon shares near 52-week high after USFDA approves key diabetes treatment drug
Shares of Biocon Ltd. gained as much as 3% in early trading on Wednesday, July 16, after the United States Food & Drug Administration...
Stocks to buy or sell today: Biocon, Voltas among 7 trading ideas for 15 July 2025
The Indian market is likely to consolidate on Tuesday, tracking mixed global cues.The Nifty future closed negatively with losses of 0.20% at 25,173 levels...
Biocon Biologics gets UK drug regulator nod for Denosumab biosimilars — Vevzuo and Evfraxy
Biocon Ltd. on Monday, July 7, said its subsidiary Biocon Biologics Ltd has secured marketing authorisation from the Medicines and Healthcare products Regulatory Agency...
